Back to Search Start Over

Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder.

Authors :
Sprenger FS
Stefanova N
Gelpi E
Seppi K
Navarro-Otano J
Offner F
Vilas D
Valldeoriola F
Pont-Sunyer C
Aldecoa I
Gaig C
Gines A
Cuatrecasas M
Högl B
Frauscher B
Iranzo A
Wenning GK
Vogel W
Tolosa E
Poewe W
Source :
Neurology [Neurology] 2015 Nov 17; Vol. 85 (20), pp. 1761-8. Date of Electronic Publication: 2015 Oct 16.
Publication Year :
2015

Abstract

Objective: To investigate the expression of α-synuclein in colonic biopsies of patients with idiopathic REM sleep behavior disorder (iRBD) and address if α-synuclein immunostaining of tissue obtained via colonic biopsies holds promise as a diagnostic biomarker for prodromal Parkinson disease (PD).<br />Methods: Patients with iRBD, patients with PD, and healthy controls were prospectively recruited to undergo colonic biopsies for comparison of α-synuclein immunoreactivity patterns between the groups by using 2 different antibodies.<br />Results: There was no difference in colonic mucosal and submucosal immunostaining between groups using the 15G7 α-synuclein antibody, which was found in almost all participants enrolled in this study. By contrast, immunostaining for serine 129-phosphorylated α-synuclein (pSyn) in submucosal nerve fibers or ganglia was found in none of 14 controls but was observed in 4 of 17 participants with iRBD and 1 out of 19 patients with PD.<br />Conclusions: The present findings of pSyn immunostaining of colonic biopsies in a substantial proportion of iRBD participants raise the possibility that this tissue marker may be a suitable candidate to study further as a prodromal PD marker in at-risk cohorts.<br /> (© 2015 American Academy of Neurology.)

Details

Language :
English
ISSN :
1526-632X
Volume :
85
Issue :
20
Database :
MEDLINE
Journal :
Neurology
Publication Type :
Academic Journal
Accession number :
26475692
Full Text :
https://doi.org/10.1212/WNL.0000000000002126